Birchtech Completes NYSE American Uplisting Following Patent Victory and Water Business Expansion

Birchtech Corp. (AMEX: BCHT), a cleantech company specializing in sustainable air and water treatment, has successfully uplisted to the NYSE American exchange from the over-the-counter market. This strategic move follows the completion of a 1-for-5 reverse stock split and a public offering of approximately 6.25 million shares of common stock at an assumed price of $2.40 per share, raising about $15 million based on the last reported sale price. The company's leadership stated the reverse stock split was intended to improve the stock price and support the uplisting, which they believe will provide access to institutional capital and enhance liquidity. The company now trades under the symbol "BCHT" on the NYSE American exchange.

The timing of this capital raise and uplisting is significant as Birchtech anticipates receiving a final judgment of $78 million from a longstanding patent lawsuit, originally filed in July 2019 against numerous defendants including major power utilities and refined coal companies. This substantial settlement, combined with the proceeds from the stock offering, provides the company with considerable financial resources. Birchtech plans to use these funds to fuel expansion in the water purification market and increase its market share across the U.S. coal-fired power fleet, potentially doubling its reach in the coming years. The company expects to secure new licenses and supply contracts, typically lasting 3-5 years, with utilities using its patented technologies for mercury emissions capture.

Concurrently, Birchtech's water treatment solutions business has gained momentum after three years of development, securing purchase orders totaling $0.9 million from a mid-Atlantic power utility. The company has also entered into an agreement with Civil & Environmental Consultants Inc. (CEC) to provide testing services to utility customers and reports a robust pipeline of potential water treatment projects. This expansion into water treatment addresses growing concerns about the need for more effective and cost-efficient methods to remove harmful contaminants from water sources, particularly persistent pollutants like PFAS, which are linked to serious health issues including low birth rates, increased cancer risks, and high blood pressure in pregnant women.

With the combination of a potential $78 million legal settlement and a $20 million offering, Birchtech is strategically positioned to leverage increasing demand for cleaner air and water solutions. The uplisting to a major exchange enhances its visibility and credibility among investors, providing a stronger platform for growth as it executes its business plans in both air and water purification sectors. The company's progress reflects broader trends in environmental regulation and public health priorities, making its technological advancements and market expansion particularly relevant for stakeholders monitoring the cleantech industry.